1. Home
  2. BOX vs PTCT Comparison

BOX vs PTCT Comparison

Compare BOX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$30.60

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$77.45

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
PTCT
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.3B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
BOX
PTCT
Price
$30.60
$77.45
Analyst Decision
Buy
Buy
Analyst Count
9
17
Target Price
$38.67
$73.76
AVG Volume (30 Days)
2.3M
1.3M
Earning Date
12-02-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
54.13
N/A
EPS
1.24
8.94
Revenue
$1,150,898,000.00
$1,779,150,000.00
Revenue This Year
$9.07
$127.32
Revenue Next Year
$7.74
N/A
P/E Ratio
$24.27
$8.78
Revenue Growth
7.21
97.54
52 Week Low
$28.00
$35.95
52 Week High
$38.80
$87.50

Technical Indicators

Market Signals
Indicator
BOX
PTCT
Relative Strength Index (RSI) 51.28 53.66
Support Level $29.42 $77.18
Resistance Level $30.69 $80.20
Average True Range (ATR) 0.58 2.17
MACD 0.04 -0.06
Stochastic Oscillator 56.80 62.03

Price Performance

Historical Comparison
BOX
PTCT

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: